01:00 PM EDT, 08/27/2025 (MT Newswires) -- Pfizer ( PFE ) and BioNTech (BNTX) said Wednesday the US Food and Drug Administration approved a supplemental license application for their LP.8.1-adapted monovalent COVID-19 vaccine for use in adults ages 65 and older and people ages 5 through 64 with at least one underlying condition that leaves them at high risk of severe outcomes from COVID-19.

Price: 25.02, Change: +0.09, Percent Change: +0.38